title: Clinical Components of Telemedicine Programs for Diabetic Retinopathy.
abstract: Diabetic retinopathy is a leading cause of new-onset vision loss worldwide. Treatments supported by large clinical trials are effective in preserving vision, but many persons do not receive timely diagnosis and treatment of diabetic retinopathy, which is typically asymptomatic when most treatable. Telemedicine evaluation to identify diabetic retinopathy has the potential to improve access to care, but there are no universal standards regarding camera choice or protocol for ocular telemedicine. We review the literature regarding the impact of imaging device, number and size of retinal images, pupil dilation, type of image grader, and diagnostic accuracy on telemedicine assessment for diabetic retinopathy. Telemedicine assessment of diabetic retinopathy has the potential to preserve vision, but further development of telemedicine specific technology and standardization of operations are needed to better realize its potential.
authors: Joslin Vision Network - Indian Health Service Teleophthalmology Program, Phoenix, AZ, USA. mark.horton@ihs.gov.
authors: Mark B
authors: MB
authors: Horton
authors: Beetham Eye Institute, Joslin Diabetes Center, Boston, MA, USA.|Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
authors: Paolo S
authors: PS
authors: Silva
authors: Beetham Eye Institute, Joslin Diabetes Center, Boston, MA, USA.|Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
authors: Jerry D
authors: JD
authors: Cavallerano
authors: Beetham Eye Institute, Joslin Diabetes Center, Boston, MA, USA.|Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
authors: Lloyd Paul
authors: LP
authors: Aiello
mesh_terms: D003930:Diabetic Retinopathy / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D017216:Telemedicine / Q000379:methods
keywords: Diabetes mellitus; Diabetic retinopathy; Telemedicine; Teleophthalmology